Steph & CO Danaher Corp Transaction History

Steph & CO

$276 Million
Q3 2024

A detailed history of Steph & CO transactions in Danaher Corp stock. As of the latest transaction made, Steph & CO holds 43 shares of DHR stock, worth $10,107. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$10,107

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$239.25 - $280.76 $10,287 - $12,072	43 New	43 $11,000
Q3 2023 Oct 26, 2023	BUY	$233.08 - $265.59 $2,796 - $3,187	12 Added 11.43%	117 $29,000
Q1 2022 Apr 15, 2022	SELL	$257.27 - $315.76 $61,230 - $75,150	-238 Reduced 69.39%	105 $31,000
Q4 2021 Jan 24, 2022	BUY	$292.08 - $329.01 $65,718 - $74,027	225 Added 190.68%	343 $113,000
Q3 2021 Oct 22, 2021	SELL	$272.21 - $332.43 $2,722 - $3,324	-10 Reduced 7.81%	118 $36,000
Q1 2021 Apr 16, 2021	SELL	$212.38 - $245.9 $3,185 - $3,688	-15 Reduced 10.49%	128 $29,000
Q2 2020 Jul 15, 2020	SELL	$128.7 - $176.83 $1,930 - $2,652	-15 Reduced 9.49%	143 $25,000
Q4 2019 Feb 24, 2020	BUY	$133.47 - $153.48 $21,088 - $24,249	158 New	158 $24,000

Others Institutions Holding DHR

# of Institutions

2,508

Shares Held

542M

Call Options Held

7.07M

Put Options Held

4.55M

Vanguard Group Inc Valley Forge, PA

59.4M
Shares

$14 Billion
0.3% of portfolio
Black Rock Inc. New York, NY

50.5M
Shares

$11.9 Billion
0.29% of portfolio
State Street Corp Boston, MA

27.5M
Shares

$6.46 Billion
0.32% of portfolio
Wellington Management Group LLP Boston, MA

23.3M
Shares

$5.48 Billion
1.16% of portfolio
Price T Rowe Associates Inc Baltimore, MD

20.5M
Shares

$4.81 Billion
0.66% of portfolio

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $171B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

News

Stay updated on Steph & CO with notifications on news.

Account